Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Open science discovery of potent noncovalent SARS-CoV-2 main protease inhibitors.

Journal article

Boby ML. et al, (2023), Science, 382

Turning high-throughput structural biology into predictive inhibitor design.

Journal article

Saar KL. et al, (2023), Proc Natl Acad Sci U S A, 120

Discovery and Development Strategies for SARS-CoV-2 NSP3 Macrodomain Inhibitors.

Journal article

Schuller M. et al, (2023), Pathogens, 12

Structure-based inhibitor optimization for the Nsp3 Macrodomain of SARS-CoV-2.

Journal article

Gahbauer S. et al, (2022), bioRxiv

Load More